GALMED PHARMACEUTICALS LTD. Income (Loss) from Equity Method Investments
GALMED PHARMACEUTICALS LTD. (GLMD) reported Income (Loss) from Equity Method Investments of $10.00 thousand for the 9-month period ending 2025-09-30, per its 6-K filed 2025-11-26.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2026-03-31
- GALMED PHARMACEUTICALS LTD. income (loss) from equity method investments for the quarter ending 2025-09-30 was $0.00.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2025-11-26 | $10.00K 6-K · filed 2025-11-26 | ||
| 2025-06-30 | $10.00K 6-K · filed 2025-08-28 | |||
| 2024-12-31 | $7.00K 20-F · filed 2026-03-31 |